BioNTech SE BNTX
NASDAQ BNTX
$103.76 +0.88 (+0.86%)
As of: Sep 4, 2026 · 3:59 PM EDT

BioNTech SE (BNTX) Change in Intangibles (2021 - 2026)

BioNTech SE (BNTX) posted Change in Intangibles of $1.3 million for Q4 2025, up 140.57% sequentially from -$3.2 million in Q3 2025, and up 104.89% YoY from $624941.5 in Q4 2024.

Analysis

BioNTech SE (BNTX) Change in Intangibles (2021 - 2026) Analysis & Trends

BioNTech SE has reported Change in Intangibles for 2 years, with the latest figure at $1.3 million in Q4 2025.

  • Quarterly Change in Intangibles rose 104.89% year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$672.4 million (changed N/A YoY) and the FY2025 annual result came in at -$648.4 million, down 265.97% from the prior year.
  • Change in Intangibles climbed to $1.3 million in Q4 2025 per BNTX's latest filing, from -$3.2 million in the prior quarter.
  • Over five years, Change in Intangibles peaked at $1.3 million in Q4 2025 and troughed at -$644.3 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 BioNTech SE 25.06 Bn 11.41 Bn 10.00 Mn 2.33 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.33 Bn
Mar 31, 2026 5.01 Bn
Dec 31, 2025 1.68 Bn
Sep 30, 2025 2.31 Bn
Jun 30, 2025 1.85 Bn
Mar 31, 2025 4.68 Bn
Dec 31, 2024 2.96 Bn
Sep 30, 2024 3.18 Bn
Jun 30, 2024 2.53 Bn
Mar 31, 2024 2.96 Bn
Dec 31, 2023 982.66 Mn
Sep 30, 2023 329.84 Mn
Mar 31, 2022 421.10 Mn
Dec 31, 2021 -9.38 Mn
Sep 30, 2021 -432.80 Mn